Journal of Nutrition EB Program 2010 Abstracts

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


J. Nutr. First published March 25, 2009; doi:10.3945/jn.108.102772
Journal of Nutrition, doi:10.3945/jn.108.102772
Vol. 139, No. 5, 1042-1048, May 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplemental Material
Right arrow All Versions of this Article:
139/5/1042    most recent
jn.108.102772v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, W.
Right arrow Articles by Chapkin, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, W.
Right arrow Articles by Chapkin, R. S.
© 2009 American Society for Nutrition


Nutritional Immunology

Dietary Curcumin and Limonin Suppress CD4+ T-Cell Proliferation and Interleukin-2 Production in Mice1–3,

Wooki Kim4,5,7, Yang-Yi Fan4,5, Roger Smith6, Bhimanagouda Patil7, Guddadarangavvanahally K. Jayaprakasha7, David N. McMurray4,5,8,9 and Robert S. Chapkin4,5,7,8,*

4 Program in Integrative Nutrition and Complex Diseases, 5 Intercollegiate Faculty of Nutrition, 6 Department of Veterinary Pathobiology, 7 Vegetable and Fruit Improvement Center, and 8 Center for Environmental and Rural Health, Texas A&M University, College Station, TX 77843; and 9 Department of Microbial and Molecular Pathogenesis, Texas A&M University System Health Science Center, College Station, TX 77843

Phytochemicals may reduce chronic inflammation and cancer risk in part by modulating T-cell nuclear factor-{kappa}B (NF-{kappa}B) activation. Therefore, we examined the effects of curcumin (Cur) and limonin (Lim) feeding on NF-{kappa}B–dependent CD4+ T-cell proliferation. DO11.10 transgenic mice (n = 5–7) were fed diets containing 1% Cur or 0.02% Lim combined with either (n-6) PUFA [5% corn oil (CO)] or (n-3) PUFA [4% fish oil+1% corn oil (FO)] for 2 wk, followed by splenic CD4+ T-cell isolation and stimulation with ovalbumin peptide 323–339 (OVA) and antigen-presenting cells from mice fed a conventional nonpurified rodent diet. Both Cur and Lim diets suppressed (P < 0.05) NF-{kappa}B p65 nuclear translocation in activated CD4+ T-cells. In contrast, activator protein-1 (c-Jun) and nuclear factor of activated T-cells c1 were not affected compared with the CO control diet (no Cur or Lim). CD4+ T-cell proliferation in response to either mitogenic anti-CD3/28 monoclonal antibodies (mAb) or antigenic stimulation by OVA was also suppressed (P < 0.05) by Cur as assessed by carboxyfluorescein succinimidyl ester staining. In contrast, interleukin-2 production was not directly associated with NF-{kappa}B status. Interestingly, dietary combination with FO enhanced the suppressive effects (P < 0.05) of Cur or Lim with respect to CD4+ T-cell proliferation in response to anti-CD3/28 mAb. These results suggest that combination chemotherapy (FO+Cur or Lim) may favorably modulate CD4+ T-cell–mediated inflammation.


* To whom correspondence should be addressed. E-mail: r-chapkin{at}tamu.edu.

Manuscript received 26 November 2008. Initial review completed 16 January 2009. Revision accepted 12 February 2009.

Published online 25 March 2009.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2009 by American Society for Nutrition